Companies: 10,795·Total market cap: $144.5T
Panacea Life Sciences Holdings, Inc.

Panacea Life Sciences Holdings, Inc.

PLSHOTCHealthcare● Active
$0.03
+$0.00(+0.00%)
Market Cap$679161
P/E Ratio
52W High$0.1996
52W Low$0.0211
Overview

Panacea Life Sciences Holdings, Inc.(PLSH)· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · PLSH · 截至 2026-06-15

财务报表

Revenue · Gross Profit · Net Income
Breakdown2025-122024-122023-122022-122021-12
Revenue
Revenue$0.91M$4.11M$2.38M$1.63M$2.06M
Cost of Revenue$2.13M$1.26M$6.47M$1.23M$1.52M
Gross Profit($1.22M)$2.85M($4.09M)$0.40M$0.54M
Gross Margin %(computed)-133.94%69.36%-171.48%24.37%26.25%
Operating Expenses
R&D Expenses$0.00M$0.00M$0.00M$0.00M$0.00M
G&A Expenses$0.00M$0.00M$1.44M$0.88M$1.14M
Total Operating Expenses$0.53M$5.42M$2.37M$5.79M$6.08M
Operating Income($1.75M)($2.58M)($5.55M)($5.40M)($5.54M)
Operating Margin %(computed)-192.56%-62.71%-232.55%-331.81%-269.00%
Interest Income$0.00M$0.00M$0.00M$0.00M$0.00M
Interest Expense$0.97M$1.83M$1.56M$2.05M$1.11M
Income Before Tax($0.42M)($0.58M)($8.02M)($9.14M)($4.78M)
Income Tax Expense$0.00M$0.00M$0.00M$0.00M$0.00M
Net Income($0.42M)($0.58M)($8.02M)($11.10M)($6.12M)
Net Margin %(computed)-45.76%-14.20%-336.08%-682.14%-297.35%
Per Share & EBITDA
EPS (Basic)$-0.01$-0.03$-0.48$-0.75$-0.34
Wtd Avg Shares59.47M18.43M16.63M14.86M17.82M
EBITDA$0.02M$2.39M($4.75M)($5.36M)($1.94M)
EBITDA Margin %(computed)2.00%58.30%-199.02%-329.65%-94.19%

数据来源:Financial Modeling Prep · 最后更新:2026-06-15 · USD · M

深入了解Panacea Life Sciences Holdings, Inc.

关于Panacea Life Sciences Holdings, Inc.(PLSH)损益表

Panacea Life Sciences Holdings, Inc.(PLSH)损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年,PLSH实现营收$0.00B,毛利润($0.00B)(毛利率-133.94%),净利润($0.00B)(净利率-45.76%)。

常见问题

PLSH · 4 问

Panacea Life Sciences Holdings, Inc.(PLSH)2025财年营收为$0.00B,同比down77.8%。

PLSH revenuePLSH salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-15